[{"Assets_0_Q3_USD":130455000.0,"CommonStockSharesOutstanding_0_Q3_shares":25187441.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-27482000.0,"NetIncomeLoss_1_Q3_USD":-14383000.0,"NetIncomeLoss_3_Q3_USD":-25939000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":20306298.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":17472403.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":20306298.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":17472403.0,"StockholdersEquity_0_Q3_USD":111156000.0,"EarningsPerShareBasic_1_Q3_USD":-0.63,"EarningsPerShareBasic_3_Q3_USD":-1.34,"EarningsPerShareDiluted_1_Q3_USD":-0.63,"EarningsPerShareDiluted_3_Q3_USD":-1.34,"Ticker":"XENE","CIK":"1582313","name":"XENON PHARMACEUTICALS INC.","OfficialName":"Xenon Pharmaceuticals Inc. Common Shares","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1764405075.0","Country":"Canada","Sector":"nan","Industry":"nan","Market":"NASDAQ","SP500":"nan","filed":"20181106"}]